AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 201 filers reported holding AXSOME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $475 | +6.5% | 6,800 | +9.7% | 0.00% | +50.0% |
Q2 2023 | $446 | +29.3% | 6,200 | +10.7% | 0.00% | 0.0% |
Q1 2023 | $345 | +6.5% | 5,600 | +33.3% | 0.00% | 0.0% |
Q4 2022 | $324 | -99.9% | 4,200 | -35.4% | 0.00% | 0.0% |
Q3 2022 | $290,000 | +16.5% | 6,500 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $249,000 | -19.7% | 6,500 | -13.3% | 0.00% | 0.0% |
Q1 2022 | $310,000 | +9.5% | 7,500 | 0.0% | 0.00% | +100.0% |
Q4 2021 | $283,000 | +38.7% | 7,500 | +21.0% | 0.00% | 0.0% |
Q3 2021 | $204,000 | -51.2% | 6,200 | 0.0% | 0.00% | -50.0% |
Q2 2021 | $418,000 | +22.9% | 6,200 | +3.3% | 0.00% | 0.0% |
Q1 2021 | $340,000 | -30.5% | 6,000 | 0.0% | 0.00% | -33.3% |
Q4 2020 | $489,000 | +14.3% | 6,000 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $428,000 | -56.7% | 6,000 | -50.0% | 0.00% | -25.0% |
Q2 2020 | $988,000 | – | 12,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 785,683 | $60,599,730 | 58.10% |
Fairmount Funds Management LLC | 2,011,647 | $155,158,333 | 24.61% |
VR Adviser, LLC | 670,718 | $51,732,479 | 8.72% |
Ghost Tree Capital, LLC | 235,000 | $18,126,000 | 7.74% |
SVB FINANCIAL GROUP | 33,849 | $2,610,773 | 7.14% |
Tri Locum Partners LP | 200,054 | $15,430,000 | 6.24% |
BVF INC/IL | 1,755,000 | $135,363,150 | 5.71% |
RTW INVESTMENTS, LP | 2,980,482 | $229,884,577 | 4.69% |
TANG CAPITAL MANAGEMENT LLC | 320,000 | $24,681,600 | 3.59% |
PFM Health Sciences, LP | 1,092,831 | $84,290,055 | 3.02% |